Skip to main content
OpenTrials

Clinical trial condition

Newly Diagnosed Multiple Myeloma

Explore clinical trials studying Newly Diagnosed Multiple Myeloma. Study availability and eligibility vary by location and protocol.

17 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Newly Diagnosed Multiple Myeloma trial results

Completed

Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06)

NCT01936532

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • CHRU - Hôpital du Haut Lévêque Bordeaux, France
  • CHRU Dijon Dijon, France
  • Centre hospitalier départemental Vendée La Roche-sur-Yon, France
  • CHRU - Hôpital Claude Huriez Lille, France
View Trial Details
Completed

A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older.

NCT00405756

Conditions
Newly Diagnosed Multiple Myeloma
Locations
  • Hematology Oncology Clinics of Australia, Level 5, Mater Medical Centre South Brisbane, Queensland, Australia
  • Royal Adelaide Hospital Institute of Medical and Veterinary Science Adelaide, South Australia, Australia
  • Royal Prince Alfred Hospital Camperdown, Australia
  • Peter MacCallum Cancer Centre Divsion of Haematology Medical Oncology East Melbourne, Australia
View all 98 locations
View Trial Details
Active, Not Recruiting

Isatuximab in Combination With Rd Compared to Rd in Elderly Patients (Aged ≥70 Years) With NDMM

NCT04891809

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Plasma Cell, +1 more
Locations
  • Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik Kufstein, Austria
  • LKH Hochsteiermark - Leoben, Abt. f. Innere Medizin, Haemato-Onkologie Leoben, Austria
  • Univ.Klinikum Krems, Klin. Abt. f. Innere Medizin 2 Mitterweng, Austria
  • PMU Salzburg: Universitätsklinik für Innere Medizin III Salzburg, Austria
View all 14 locations
View Trial Details
Active, Not Recruiting

Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM

NCT03948035

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Univ. Klinikum Krems Krems, Lower Austria, Austria
  • Universitätklinikum St. Pölten Sankt Pölten, Lower Austria, Austria
  • LKH-Universitätsklinikum Graz Graz, Styria, Austria
  • Medizinische Universität Innsbruck Innsbruck, Tyrol, Austria
View all 56 locations
View Trial Details
Active, Not Recruiting

Treatment for Elderly Fit Newly Diagnosed Multiple Myeloma Patients Aged Between 65 and 80 Years

NCT03742297

Conditions
Newly Diagnosed Multiple Myeloma
Locations
  • Complejo Hospitalario Universitario A Coruña A Coruña, Spain
  • Complejo Hospitalario Universitario de Albacete Albacete, Spain
  • Hospital General Universitario de Alicante Alicante, Spain
  • Hospital Universitari Germans Trias i Pujol (ICO Badalona) Badalona, Spain
View all 58 locations
View Trial Details

Related conditions